Semin intervent Radiol 2005; 22(3): 157-161
DOI: 10.1055/s-2005-921949
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Venous Pathophysiology

Chieh-Min Fan1
  • 1Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Oktober 2005 (online)

ABSTRACT

Chronic venous insufficiency and varicose veins are among the most prevalent medical problems in the adult population. Historically, our understanding of venous reflux disease focused upon the anatomical mechanisms of valvular incompetence. More recent investigations into the cellular and molecular aspects of venous insufficiency have shown that the disease is a complex multifactorial process reflecting both systemic abnormalities of connective tissue synthesis and cellular inflammatory reaction. New minimally invasive endovenous treatments for primary lower extremity venous insufficiency have spurred growing clinical interest in this disease. The intent of this review article is to discuss the prevalence, epidemiological risk factors, and current theories of the pathophysiology of primary venous insufficiency.

REFERENCES

  • 1 Callam M J. Epidemiology of varicose veins.  Br J Surg. 1994;  81 167-173
  • 2 Fowkes F R, Evans C J, Lee A J. Prevalence and risk factors of chronic venous insufficiency.  Angiology. 2001;  52(suppl 1) S5-S15
  • 3 Evans C J, Fowkes F GR, Ruckley D V, Lee A J. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh vein study.  J Epidemiol Community Health. 1999;  53 149-153
  • 4 Brand F N, Dannnenberg A L, Abbott R D, Kannel W B. The epidemiology of varicose veins: the Framingham study.  Am J Prev Med. 1988;  4 96-101
  • 5 Sisto T, Reunanen A, Laurikka J et al.. Prevalence and risk factors of varicose veins in the lower extremities: mini-Finland health survey.  Eur J Surg. 1995;  161 405-414
  • 6 Cesarone M R, Belcaro G, Nicolaides A N et al.. “Real” epidemiology of varicose veins and chronic venous diseases: the San Valentino vascular screening project.  Angiology. 2002;  53 119-130
  • 7 Laurikka J O, Sisto T, Tarkka M R, Auvinen O, Hakama M. Risk indicators for varicose veins in forty- to sixty-year-olds in the Tampere varicose vein study.  World J Surg. 2002;  26 648-651
  • 8 Hirai M, Naiki K, Nakayama R. Prevalence and risk factors of varicose veins in Japanese women.  Angiology. 1990;  41 228-232
  • 9 Stansby G. Women, pregnancy, and varicose veins.  Lancet. 2000;  355 1117-1118
  • 10 Ciardullo A V, Panico S, Bellati C et al.. High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women.  J Vasc Surg. 2000;  32 544-549
  • 11 Cornu-Thenard A, Boivin P, Baud J M, de Vincenzi I, Carpentier P H. Importance of the familial factor in varicose disease.  J Dermatol Surg Oncol. 1994;  20 318-326
  • 12 Iannuzzi A, Panico S, Ciardullo A V et al.. Varicose veins of the lower limbs and venous capacitance in postmenopausal women: relationship with obesity.  J Vasc Surg. 2002;  36 965-968
  • 13 Fowkes F GR, Lee A J, Evans C J et al.. Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh vein study.  Int J Epidemiol. 2001;  30 846-852
  • 14 Hobson J. Venous insufficiency at work.  Angiology. 1997;  48 577-582
  • 15 Goldman M P, Wiess R A, Bergan J J. Varicose Veins and Telangiectasias: Diagnosis and Treatment. 2nd ed. St. Louis; Quality Medical Publishing 1999: 12-37
  • 16 Rose S S, Ahmed A. Some thoughts on the aetiology of varicose veins.  J Cardiovasc Surg (Torino). 1986;  27 534-543
  • 17 Sansilvestri-Morel P, Rupin A, Kern P et al.. Imbalance in the synthesis of collagen type 1 and collagen type 3 in smooth muscle cells derived from human varicose veins.  J Vasc Res. 2001;  38 560-568
  • 18 Sansilvestri-Morel P, Rupin A, Jaisson S et al.. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells.  Circulation. 2002;  106 479-483
  • 19 Edwards J E, Edwards E A. The saphenous valves in varicose veins.  Am Heart J. 1940;  19 338
  • 20 Yamamoto N, Unno N, Mitsuoka H et al.. Preoperative and intraoperative evaluation of diameter-reflux relationship of calf perforating veins in patients with primary varicose vein.  J Vasc Surg. 2002;  36 1225-1230
  • 21 Delis K T, Husmann M, Kalodiki E, Wolfe J H, Nicolaides A N. In situ hemodynamics of perforating veins in chronic venous insufficiency.  J Vasc Surg. 2001;  33 773-782
  • 22 Stuart W P, Adam D J, Allan P L, Ruckley V, Bradbury A W. The relationship between the number, competence, and diameter of medial calf perforating veins and the clinical status in healthy subjects and patients with lower-limb venous disease.  J Vasc Surg. 2000;  32 138-143
  • 23 Schmid-Schonbein G W, Takase S, Bergan J J. New advances in the understanding of the pathophysiology of chronic venous insufficiency.  Angiology. 2001;  52(suppl 1) S27-S34
  • 24 Smith P. Update on chronic-venous-insufficiency-induced inflammatory processes.  Angiology. 2001;  52(suppl 1) S35-S42
  • 25 Kurz X, Lamping D L, Kahn S R et al.. Do varicose veins affect quality of life? Results of an international population-based study.  J Vasc Surg. 2001;  34 641-648
  • 26 Abenhaim L, Kurz X. The VEINES study (VEnous INsufficiency Epidemiologic and economic Study): an international cohort study on chronic venous disorders of the leg.  Angiology. 1997;  48 59-66

Chieh-Min FanM.D. 

Department of Radiology, Massachusetts General Hospital, Boston, MA 02114